CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Alnylam Europe's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 15, 2017Methods And Medicament For Inhibition The Expression Of A Defined Gene1

Top competitors of Alnylam Europe

Top competitors of Alnylam Europe based on patent oppositions.